Paula Ravasco

Dr. Paula Ravasco

1. Católica Medical School, UCP Faculty of Medicine, Porto, Portugal
+1

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in The Lancet Oncology
Verified
Journal Article
Closed access
KFKenneth Fearon
Kenneth Fearon
FSFlorian Strasser
Florian Strasser
SAStefan D Anker
Stefan D Anker
IBIngvar Bosaeus
Ingvar Bosaeus
EBEduardo Bruera
Eduardo Bruera
Vickie Elaine BaracosVickie Elaine Baracos
Vickie Elaine Baracos

1 February 2017 in Clinical Nutrition
Verified
Journal Article
Closed access
JAJann Arends
Jann Arends
PBPatrick Bachmann
Patrick Bachmann
VBVickie Baracos
Vickie Baracos
NBNicole Barthelemy
Nicole Barthelemy
HBHartmut Bertz
Hartmut Bertz
Jean Charles PreiserJean Charles Preiser
Jean Charles Preiser

1 May 2021 in Clinical Nutrition
Verified
Journal Article
Closed access
MMMaurizio Muscaritoli
Maurizio Muscaritoli
JAJann Arends
Jann Arends
PBPatrick Bachmann
Patrick Bachmann
VBVickie Baracos
Vickie Baracos
NBNicole Barthelemy
Nicole Barthelemy
SBStephan C. Bischoff
Stephan C. Bischoff

1 June 2021 in ESMO Open
Verified
Journal Article
Open access
JAJ. Arends
J. Arends
FSF. Strasser
F. Strasser
SGS. Gonella
S. Gonella
TST.S. Solheim
T.S. Solheim
CMC. Madeddu
C. Madeddu
CRC.I. Ripamonti
C.I. Ripamonti
• This ESMO Clinical Practice Guideline provides key recommendations for managing cancer-related cachexia. • It covers screening, assessment and multimodal management of cancer cachexia. • All recommendations were compiled by a multidisciplinary group of experts. • Recommendations are based on available scientific data and the author's expert opinion.

1 August 2005 in Head & Neck
Verified
Journal Article
Closed access
PDF file
Paula Ravasco, MD, RD, MSc, PhDPaula Ravasco, MD, RD, MSc, PhD
Paula Ravasco, MD, RD, MSc, PhD
IMIsabel Monteiro-Grillo
Isabel Monteiro-Grillo
Pedro Marques-VidalPedro Marques-Vidal
Pedro Marques-Vidal
MCMaria Ermelinda Camilo
Maria Ermelinda Camilo

1 March 2005 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
Paula Ravasco, MD, RD, MSc, PhDPaula Ravasco, MD, RD, MSc, PhD
Paula Ravasco, MD, RD, MSc, PhD
IMIsabel Monteiro-Grillo
Isabel Monteiro-Grillo
Pedro Marques-VidalPedro Marques-Vidal
Pedro Marques-Vidal
MCMaria Ermelinda Camilo
Maria Ermelinda Camilo
Purpose To investigate the impact of dietary counseling or nutritional supplements on outcomes in cancer patients: nutritional, morbidity, and quality of life (QoL) during and 3 months after radiotherapy. Patients and Methods A total of 111 colorectal cancer outpatients referred for radiotherapy, stratified by staging, were randomly assigned: group 1 (G1; n = 37), dietary counseling (regular foods); group 2 (G2; n = 37), protein supplements; and group 3 (G3; n = 37), ad libitum intake. Nutritional intake (diet history), status (Ottery's Subjective Global Assessment), and QoL (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire version 3.0) were evaluated at baseline, at the end, and 3 months after radiotherapy. Results At radiotherapy completion, energy intake increased in G1/G2 (P ≤ .04), G1 more than G2 (P = .001), and decreased in G3 (P < .01). Protein intake increased in G1/G2 (P ≤ .007), G1 less than G2 (not significant), and decreased in G3 (P < .01). At 3 months, G1 maintained nutritional intake and G2/G3 returned to baseline. After radiotherapy and at 3 months, rates of anorexia, nausea, vomiting, and diarrhea were higher in G3 (P < .05). At radiotherapy completion, in G1 all QoL function scores improved proportionally to adequate intake or nutritional status (P < .05); whereas in G2 only three of six function scores improved proportionally to protein intake (P = .04), and in G3 all scores worsened (P < .05). At 3 months, G1 patients maintained/improved function, symptoms, and single-item scores (P < .02); in G2, only few function and symptom scales improved (P < .05); in G3, QoL remained as poor as after radiotherapy. In G1/G2, respectively, improvement/deterioration of QoL correlated with better or poorer intake or nutritional status (P < .003). Conclusion During radiotherapy, both interventions positively influenced outcomes; dietary counseling was of similar or higher benefit, whereas even 3 months after RT, it was the only method to sustain a significant impact on patient outcomes.